Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations.

Spiridon Papapetropoulos, Carlos Singer

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

BACKGROUND: In oromandibular dystonia (OMD) abnormal repetitive contractions of masticatory, facial, and lingual muscles as well as the presence of orobuccolingual (OBL) dyskinesias may interfere with the appropriate performance of tasks such as chewing and swallowing leading to significant dysphagia and weight loss. We present here the clinical characteristics and treatment variables of a series of patients that developed an OMD-associated eating dysfunction. METHODS: We present a series of patients diagnosed and followed-up at the Movement Disorders Clinic of the Department of Neurology of University of Miami, Miller School of Medicine over a 10-year period. Patients were treated with botulinum toxin injections according to standard methods. RESULTS: Five out of 32 (15.6%) OMD patients experienced symptoms of eating dysfunction associated with OMD. Significant weight loss was reported in 3/5 patients (ranged for 13-15 lbs). Two patients regained the lost weight after treatment and one was lost to follow-up. Tetrabenazine in combination with other antidystonic medication and/or botulinum toxin injections provided substantial benefit to the patients with dysphagia caused by OMD. CONCLUSION: Dystonic eating dysfunction may occasionally complicate OMD leading to weight loss. Its adequate characterization at the time of history taking and clinical examination should be part of outcome measurements of the anti-dystonic treatment in clinical practice.

Original languageEnglish
JournalHead & face medicine
Volume2
StatePublished - Dec 1 2006

Fingerprint

Dystonia
Eating
Weight Loss
Botulinum Toxins
Deglutition Disorders
Therapeutics
Tetrabenazine
Facial Muscles
Injections
Mastication
Lost to Follow-Up
Dyskinesias
Movement Disorders
Task Performance and Analysis
Deglutition
Neurology
Tongue
Medicine
Weights and Measures

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Eating dysfunction associated with oromandibular dystonia : clinical characteristics and treatment considerations. / Papapetropoulos, Spiridon; Singer, Carlos.

In: Head & face medicine, Vol. 2, 01.12.2006.

Research output: Contribution to journalArticle

@article{5e544fa3f90248d697284cf43c021588,
title = "Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations.",
abstract = "BACKGROUND: In oromandibular dystonia (OMD) abnormal repetitive contractions of masticatory, facial, and lingual muscles as well as the presence of orobuccolingual (OBL) dyskinesias may interfere with the appropriate performance of tasks such as chewing and swallowing leading to significant dysphagia and weight loss. We present here the clinical characteristics and treatment variables of a series of patients that developed an OMD-associated eating dysfunction. METHODS: We present a series of patients diagnosed and followed-up at the Movement Disorders Clinic of the Department of Neurology of University of Miami, Miller School of Medicine over a 10-year period. Patients were treated with botulinum toxin injections according to standard methods. RESULTS: Five out of 32 (15.6{\%}) OMD patients experienced symptoms of eating dysfunction associated with OMD. Significant weight loss was reported in 3/5 patients (ranged for 13-15 lbs). Two patients regained the lost weight after treatment and one was lost to follow-up. Tetrabenazine in combination with other antidystonic medication and/or botulinum toxin injections provided substantial benefit to the patients with dysphagia caused by OMD. CONCLUSION: Dystonic eating dysfunction may occasionally complicate OMD leading to weight loss. Its adequate characterization at the time of history taking and clinical examination should be part of outcome measurements of the anti-dystonic treatment in clinical practice.",
author = "Spiridon Papapetropoulos and Carlos Singer",
year = "2006",
month = "12",
day = "1",
language = "English",
volume = "2",
journal = "Head and Face Medicine",
issn = "1746-160X",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Eating dysfunction associated with oromandibular dystonia

T2 - clinical characteristics and treatment considerations.

AU - Papapetropoulos, Spiridon

AU - Singer, Carlos

PY - 2006/12/1

Y1 - 2006/12/1

N2 - BACKGROUND: In oromandibular dystonia (OMD) abnormal repetitive contractions of masticatory, facial, and lingual muscles as well as the presence of orobuccolingual (OBL) dyskinesias may interfere with the appropriate performance of tasks such as chewing and swallowing leading to significant dysphagia and weight loss. We present here the clinical characteristics and treatment variables of a series of patients that developed an OMD-associated eating dysfunction. METHODS: We present a series of patients diagnosed and followed-up at the Movement Disorders Clinic of the Department of Neurology of University of Miami, Miller School of Medicine over a 10-year period. Patients were treated with botulinum toxin injections according to standard methods. RESULTS: Five out of 32 (15.6%) OMD patients experienced symptoms of eating dysfunction associated with OMD. Significant weight loss was reported in 3/5 patients (ranged for 13-15 lbs). Two patients regained the lost weight after treatment and one was lost to follow-up. Tetrabenazine in combination with other antidystonic medication and/or botulinum toxin injections provided substantial benefit to the patients with dysphagia caused by OMD. CONCLUSION: Dystonic eating dysfunction may occasionally complicate OMD leading to weight loss. Its adequate characterization at the time of history taking and clinical examination should be part of outcome measurements of the anti-dystonic treatment in clinical practice.

AB - BACKGROUND: In oromandibular dystonia (OMD) abnormal repetitive contractions of masticatory, facial, and lingual muscles as well as the presence of orobuccolingual (OBL) dyskinesias may interfere with the appropriate performance of tasks such as chewing and swallowing leading to significant dysphagia and weight loss. We present here the clinical characteristics and treatment variables of a series of patients that developed an OMD-associated eating dysfunction. METHODS: We present a series of patients diagnosed and followed-up at the Movement Disorders Clinic of the Department of Neurology of University of Miami, Miller School of Medicine over a 10-year period. Patients were treated with botulinum toxin injections according to standard methods. RESULTS: Five out of 32 (15.6%) OMD patients experienced symptoms of eating dysfunction associated with OMD. Significant weight loss was reported in 3/5 patients (ranged for 13-15 lbs). Two patients regained the lost weight after treatment and one was lost to follow-up. Tetrabenazine in combination with other antidystonic medication and/or botulinum toxin injections provided substantial benefit to the patients with dysphagia caused by OMD. CONCLUSION: Dystonic eating dysfunction may occasionally complicate OMD leading to weight loss. Its adequate characterization at the time of history taking and clinical examination should be part of outcome measurements of the anti-dystonic treatment in clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=40649108239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40649108239&partnerID=8YFLogxK

M3 - Article

C2 - 17156419

AN - SCOPUS:40649108239

VL - 2

JO - Head and Face Medicine

JF - Head and Face Medicine

SN - 1746-160X

ER -